These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 455579)

  • 1. Vindesine. A short review of preclinical and first clinical data.
    Dyke RW; Nelson RL; Brade WP
    Cancer Chemother Pharmacol; 1979; 2(4):229-32. PubMed ID: 455579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vindesine: a new antineoplastic drug].
    Baccarani M; Corbelli G
    G Clin Med; 1981 Feb; 62(2):129-34. PubMed ID: 7016650
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).
    Dyke RW; Nelson RL
    Cancer Treat Rev; 1977 Jun; 4(2):135-42. PubMed ID: 329987
    [No Abstract]   [Full Text] [Related]  

  • 4. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vinca alkaloids, a newer group of anti-neoplastic drugs].
    Hansen I; Nissen NI
    Ugeskr Laeger; 1972 Jun; 134(25):1315-21. PubMed ID: 4340246
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Howard SM; Theologides A; Sheppard JR
    Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
    Barnett CJ; Cullinan GJ; Gerzon K; Hoying RC; Jones WE; Newlon WM; Poore GA; Robison RL; Sweeney MJ; Todd GC; Dyke RW; Nelson RL
    J Med Chem; 1978 Jan; 21(1):88-96. PubMed ID: 412968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.
    Nelson RL; Dyke RW; Root MA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():17-24. PubMed ID: 7438117
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
    Jordan MA; Himes RH; Wilson L
    Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vindesine, a new cytostatic agent from the vinca alkaloids].
    Goldhirsch A; Joss R; Sonntag RW; Brunner KW
    Dtsch Med Wochenschr; 1980 Jun; 105(26):931-5. PubMed ID: 6931709
    [No Abstract]   [Full Text] [Related]  

  • 16. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs.
    Todd GC; Gibson WR; Morton DM
    J Toxicol Environ Health; 1976 May; 1(5):843-50. PubMed ID: 1271489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of two Vinca alkaloids on B16 melanoma in vitro.
    Donoso JA; Himes RH
    Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.
    Maral R; Bourut C; Chenu E; Mathé G
    Cancer Lett; 1984 Feb; 22(1):49-54. PubMed ID: 6697321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
    Conrad RA; Cullinan GJ; Gerzon K; Poore GA
    J Med Chem; 1979 Apr; 22(4):391-400. PubMed ID: 430477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.